Renalytix (

1. Activist stake, 2 Oct: LONDON and NEW YORK, 1 October 2026 – Renalytix plc (LSE: RENX) (OTCQB: RNLXY), a precision medicine diagnostics company focused on kidney disease, announces that on 29 September 2026, certain investment vehicles connected with Christopher Mills, Non-Executive Director, have completed the... RNS
2. Watch: next signal would be “AGM revolt” – A resolution fails or draws a large vote against, within 365 days.

AI summary with checked claims arrives with the nightly run. These lines are the matched extracts.